Neuroleptic malignant syndrome

Prachi Mehndiratta, Yonatan Spolter, Blessing Igboeli, Martha Sajatovic, Peter F. Buckley

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Scopus citations

Abstract

Neuroleptic malignant syndrome (NMS) is usually a serious neurologic side effect of antipsychotic therapy and characterized by fever, altered mental state, muscular rigidity, and dysautonomia. This chapter provides a contemporary account of NMS, a synthesis of a voluminous and perplexing literature on its pathobiology and management, and gives clear guidelines on the care and prognosis thereafter for patients who develop NMS.

Original languageEnglish (US)
Title of host publicationNeuromuscular Disorders in Clinical Practice
PublisherSpringer New York
Pages1487-1500
Number of pages14
Volume9781461465676
ISBN (Electronic)9781461465676
ISBN (Print)1461465664, 9781461465669
DOIs
Publication statusPublished - Nov 1 2014

    Fingerprint

Keywords

  • Neuroleptic malignant syndrome
  • antipsychotics
  • neuroleptics
  • serotonin syndrome

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Mehndiratta, P., Spolter, Y., Igboeli, B., Sajatovic, M., & Buckley, P. F. (2014). Neuroleptic malignant syndrome. In Neuromuscular Disorders in Clinical Practice (Vol. 9781461465676, pp. 1487-1500). Springer New York. https://doi.org/10.1007/978-1-4614-6567-6_74